(c) 2023 PillSync.com

Ranitidine (ranitidine hydrochloride 150 mg) Dailymed

  1. Human OTC
  2. Archived
    • May Be Discontinued
      Try Other Labelers
  3. Apotex Corp.

Generic: ranitidine hydrochloride

Ranitidine tablet, film coated - (ranitidine hydrochloride 150 mg) image
view more pill photos

IMPRINT: APO RAN 150     SHAPE: round
    COLOR: blue

All Imprints

ranitidine 150 mg oral tablet - apo ran 150 round blue

  1. FDA Adverse Reactions

Go PRO for all pill images

Active Ingredient (in Each Tablet)


Ranitidine 150 mg (as ranitidine hydrochloride, USP 168 mg)

Purpose


Acid reducer

Uses

  • relieves heartburn associated with acid indigestion and sour stomach
  • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Warnings


Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers

Do not use

  • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
  • with other acid reducers
  • if you have kidney disease, except under the advice and supervision of a doctor

Ask a doctor before use if you have

  • had heartburn over 3 months. This may be a sign of a more serious condition.
  • heartburn with lightheadedness, sweating or dizziness 
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
  • frequent chest pain 
  • frequent wheezing, particularly with heartburn
  • unexplained weight loss
  • nausea or vomiting
  • stomach pain

Stop use and ask a doctor if

  • your heartburn continues or worsens
  • you need to take this product for more than 14 days

OTC - PREGNANCY OR BREAST FEEDING SECTION


If pregnant or breast-feeding ,  ask a health professional before use. 

OTC - KEEP OUT OF REACH OF CHILDREN SECTION


Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • adults and children 12 years and over:
    • to relieve symptoms, swallow 1 tablet with a glass of water
    • to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
    • can be used up to twice daily (do not take more than 2 tablets in 24 hours)
    • do not chew tablet
  • children under 12 years: ask a doctor

Other Information

  • do not use if individual buler unit is open or torn
  • store at 20°C to 25°C (68°F to 77°F)
  • avoid excessive heat or humidity
  • this product is sodium and sugar free

Inactive Ingredients


carnauba wax, colloidal silicon dioxide, cool vanilla mint flavor, FD&C blue #1, hypromellose, magnesium stearate, microcrystalline cellulose, polydextrose, titanium dioxide

Questions Or Comments?


Call 1-800-706-5575 (Monday to Friday 8:30 a.m. – 5:00 p.m. Eastern Standard Time)

Read the directions, consumer information leaflet and warnings before use. Keep the carton. It contains important information.

*This product is not manufactured or distributed by Boehringer Ingelheim Pharmaceuticals Inc., distributor of Zantac 150® Cool Mint Tablets. Zantac 150® is a registered trademark of Boehringer Ingelheim Pharmaceuticals Inc.

Principal Display Panel - 150 Mg 24s Blister Carton


Maximum Strength

Ranitidine Tablets USP, 150 mg (Cool Mint Tablets)

Acid Reducer

Prevents & Relieves Heartburn

Associated with Acid Indigestion & Sour Stomach

Releases a Cooling Sensation in Mouth & Throat

Distributed by: Apotex Corp. Weston, Florida 33326, USA

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site